Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Food Allergy Treatment Market Is Set to Triple — What it Means for Patients

Microbiome Therapies Show Potential in Food Allergy Research

Sublingual Epinephrine Advances as FDA Clarifies Requirements for Approval

Experimental KIC-IT Protocol Shows Early Success in Reversing Infant Food Allergies

Dupilumab Shows Promise for Patients Struggling With OIT Side Effects

Study: The Effect of OIT in Severe Milk, Peanut and Egg...

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

Study: Nine Children Suffer Severe Symptoms in OIT Trial

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

Eczema Drug Makes Significant Progress as EoE Treatment

DBV Completes Phase III Study of Peanut Patch

Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results

FDA Grants Kaleo Priority Review Status for Auvi-Q Designed for Infants...

New Gene Therapy Could Retrain Immune System to 'Forget' Allergy

Your School On Our Map

Put Your School on the Map